Genmont Biotech Inc. (3164) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genmont Biotech Inc. (3164:TWSE), powered by AI.

Current Price
$16.40
Sector
Healthcare
What is the Genmont Biotech Inc. stock price forecast?

Genmont Biotech Inc. is currently trading at $16.40. View real-time AI analysis on Alpha Lenz.

What is Genmont Biotech Inc. insider trading activity?

View the latest insider trading data for Genmont Biotech Inc. on Alpha Lenz.

What is Genmont Biotech Inc.'s P/E ratio?

View Genmont Biotech Inc.'s valuation metrics on Alpha Lenz.

Genmont Biotech Inc.

TWSE · 3164
NT$16.40+0.00(+0.00%)
Ask about Genmont Biotech Inc.'s future dividend policy...
Alpha Chat Insight

Genmont Biotech Inc.'s ROE is 4.3%. Explore profitability and growth together.

Ask for details

Company Overview

Genmont Biotech Inc. is a biotechnology company focused on developing, producing, and distributing probiotic products aimed at promoting health and wellness. Its primary function is to leverage cutting-edge research and technology in the field of microbiology to create effective probiotic solutions. The company’s offerings cater to a diverse range of applications, from dietary supplements to functional foods, targeting both individual consumers and various industries, including nutraceuticals and pharmaceuticals. Genmont Biotech Inc. plays a pivotal role in the global wellness market by continually advancing the understanding of probiotics' benefits. Established as a leader in its field, the company is recognized for its commitment to quality and innovation, often collaborating with academic institutions for research and development. As health and wellness trends gain momentum worldwide, Genmont Biotech Inc. positions itself at the forefront of contributing to the evolving landscape of consumer health products.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$401.23MRevenue
0.00Shares Out
0Employees

Margins

62.72%Gross
33.72%EBITDA
14.57%Operating
15.87%Pre-Tax
11.96%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

2.87%Rev 3Yr
4.29%Rev 5Yr
-0.95%Op Inc 3Yr
-3.63%Op Inc 5Yr
0.36%Net Inc 3Yr
-4.44%Net Inc 5Yr

Returns

2.84%ROA
4.26%ROE
4.01%ROIC

Financial Health

NT$103.73MCash & Cash Equivalents
NT$111.62MNet Debt
14.85%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Genmont Biotech Inc. (ticker: 3164) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 16.4 with a P/E ratio of -x and P/B of -x.

ROE is 4.26% and operating margin is 14.57%. Annual revenue is $401M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Genmont Biotech Inc. (3164) Stock Forecast 2026 $16.40 — Price, Financials & Analyst Targets | Alpha Lenz